dc.contributor.author |
Ciobanu, Natalia |
|
dc.date.accessioned |
2019-06-25T00:41:50Z |
|
dc.date.available |
2019-06-25T00:41:50Z |
|
dc.date.issued |
2015 |
|
dc.identifier.issn |
0041-6940 |
|
dc.identifier.uri |
http://repository.usmf.md/handle/20.500.12710/3101 |
|
dc.description |
Institutul de Medicină Urgentă, Chişinău, Republica Moldova |
en_US |
dc.description.abstract |
Stroke is one of the most important public health issues,
with a strong socio-economic impact worldwide and is also a
major cause of disability in highly developed countries. The
current incidence of stroke and the lack of effective treatment
measures have led to the need for further research risk factors.
The metabolic syndrome represents one of most important
elements of the pathogenesis of strokes. Insulin resistance is
proposed as the basic factor that determines other disorders
in this syndrome. Atherosclerosis, regarded as a metabolic
complication, pay attention towards peroxisome proliferator
activated receptors (PPAR), transcription factors involved in
lipid metabolism, inflammation and atheromatosis.
Accidentul vascular cerebral (AVC) este una din cele mai
importante probleme de sănătate publică, cu un puternic impact
socio-economic la nivel mondial, fiind totodată şi o cauza
majoră a dizabilităţilor în ţările înalt dezvoltate. Incidenţa
actuală a accidentelor vasculare cerebrale şi lipsa unor măsuri
eficiente de tratament au dus la necesitatea aprofundării cercetării
factorilor de risc. Sindromul metabolic reprezintă una
dintre verigile principale ale patogeniei accidentelor vasculare
cerebrale. Rezistenţa la insulină este propusă ca factor de bază
ce determină celelalte tulburări din cadrul acestui sindrom.
Ateroscleroza, privită ca o complicaţie metabolică, îndreaptă
atenţia către receptorii activaţi de proliferatorii peroxizomilor
(PPAR), factori de transcripţie implicaţi în metabolismul lipidic,
inflamaţie şi ateromatoză. |
en_US |
dc.language.iso |
ro |
en_US |
dc.publisher |
Archives of the Balkan Medical Union |
en_US |
dc.subject |
Peroxisome Proliferator- Activated Receptors (PPAR) |
en_US |
dc.subject |
Glitazone |
en_US |
dc.subject |
Fibrates |
en_US |
dc.subject.mesh |
Metabolic Syndrome |
en_US |
dc.subject.mesh |
Stroke |
en_US |
dc.subject.mesh |
Peroxisome Proliferator-Activated Receptors |
en_US |
dc.subject.mesh |
Thiazolidinediones |
en_US |
dc.subject.mesh |
Fibric Acids |
en_US |
dc.title |
Sindromul metabolic şi accidentul vascular cerebral ischemic, rolul receptorilor activaţi de proliferatorii peroxizomilor (PPAR). Review |
en_US |
dc.title.alternative |
Metabolic syndrome and stroke, role of peroxisome proliferator-activated receptors (PPAR) (review) |
en_US |
dc.type |
Article |
en_US |